Zymo’s DNA Purification Products to be Sold through VWR’s North American Distribution Channels IRVINE, Calif. — The management at Zymo Research Corp. announced today a joint agreement with VWR to sell and distribute Zymo Research’s DNA purification, RNA extraction, microbiomic analysis, and epigenetics products throughout North America. VWR (NASDAQ: VWR), headquartered in Radnor, PA is the leading, global, independent provider of products, services, and […]

  Innovative and relevant models for understanding alpha-synuclein biology and Parkinson’s disease pathogenesis in vivo Cambridge, UK: Horizon Discovery (LSE: HZD) (“Horizon”), a global leader in gene editing and gene modulation technologies, in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), today introduced two new gene knock-out and knock-in rat models for investigating the […]

LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that Dr. Daniel Kephart, formerly chief scientific officer, has resigned from the company to pursue alternative opportunities. Dr. Kephart had served in this capacity since December 2016. Neogen Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated […]

Early Evaluators Report Faster Sequencing and Consistent Quality at a Lower Cost SHENZHEN, China — MGI Tech, a subsidiary corporation of BGI, launched two new next generation genetic sequencers, MGISEQ-2000 and MGISEQ-200, at the 12th International Conference on Genomics (ICG-12) in Shenzhen. The products were unveiled at the conference, held at the China National GeneBank from Oct. […]

Trusted QIAGEN partners can now increase their speed to market by leveraging the company’s industry expertise, world-class manufacturing and thousands of product formulations Beverly, Mass. – QIAGEN today announced the launch of its Custom Solutions business, extending its commitment to providing life sciences and molecular diagnostics companies with the tools and expertise required to quickly build […]

Collaboration will use PanCancer IO360 Assay Which Incorporates the Tumor Inflammation Signature (TIS) and mismatch repair genes (MMR) for assessment of MSI-H phenotype SEATTLE and PITTSBURGH — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and the NSABP Foundation, Inc. (NSABP), an academic research organization supported by the National Cancer Institute (NCI) and industry funding, […]

Illumina and Pillar Biosciences, Inc. today announced an agreement to develop next-generation sequencing (NGS) based in vitro diagnostic (IVD) tests. Under the terms of the agreement, Pillar Biosciences will lead the development of a series of diagnostic tests that will be run on the Illumina MiSeq™Dx instrument. Pillar Biosciences has developed Stem Loop Inhibition Mediated […]

PierianDx announced today two key additions that will expand the organization’s reach into health systems and global markets while deepening clinical expertise. BG Jones has been named Senior Vice President of Business Development and will lead the expansion of PierianDx’s clinical genomics platform into health systems in the U.S. and global markets while cultivating partner […]

Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed Katherine Eade and Thomas Loewald as Class II directors of the Board of Directors, effective as of October 24, 2017. Ms. Eade is Director, M&A Law and Transactions at Corning.  Prior to […]

AMSBIO announces the launch of a new service for synthesis of custom-designed, highly modified mRNAs prepared by an advantageous in vitro transcription methodology. Traditional approaches for engineering changes in cellular expression profiles have employed mostly DNA or RNA based viral and non-viral vectors. Unfortunately, these methods carry high risks, due to genomic integration with permanent […]